275
Views
6
CrossRef citations to date
0
Altmetric
Dermatogeriatrics

Bullous pemphigoid: a case series with emphasis on long-term remission off therapy

&
Pages 327-331 | Received 17 Dec 2011, Accepted 29 Dec 2011, Published online: 04 Mar 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Astrid M. van Huizen, Francisca M. Vermeulen, Cathelijne M. J. M. Bik, Rinke Borgonjen, Saskia A. T. Karsch, Rosanna A. Kuin, Louise A. A. Gerbens & Phyllis I. Spuls. (2022) On which evidence can we rely when prescribing off-label methotrexate in dermatological practice? – a systematic review with GRADE approach. Journal of Dermatological Treatment 33:4, pages 1947-1966.
Read now

Articles from other publishers (5)

Agoritsa Gravani, Georgios Gaitanis, Panagiota Spyridonos, Ioannis Alexis, Stelios Tigas & Ioannis D. Bassukas. (2022) Methylprednisolone Plus Low-Dose Methotrexate for Bullous Pemphigoid—A Single Center Retrospective Analysis. Journal of Clinical Medicine 11:11, pages 3193.
Crossref
M. Castel, M. Alexandre, L. Jelti, A. Pham-Ledard, M. Viguier, C. Bédane, E. Tancrède-Bohin, P. Musette, P. Carvalho, N. Cordel, F. Caux & P. Joly. (2022) Updated French guidelines for the therapeutic management of bullous pemphigoid. Annales de Dermatologie et de Vénéréologie 149:2, pages 81-91.
Crossref
Danka Svecova. 2018. Autoimmune Bullous Diseases. Autoimmune Bullous Diseases.
Luis J. Borda, Andrew Ross, Gabriel Villada & Clara Milikowski. (2018) Acute mucocutaneous methotrexate toxicity with marked tissue eosinophilia. BMJ Case Reports, pages bcr-2017-221489.
Crossref
. (2014) Methotrexate/prednisone. Reactions Weekly 1521:1, pages 113-113.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.